{
    "id": "5e2a04feaa19d74431000009",
    "question": "Can LB-100 downregulate miR-33?",
    "options": {
        "A": "yes",
        "B": "no"
    },
    "answer": "B",
    "predict": "{\"step_by_step_thinking\": \"To answer this question, we need to understand what LB-100 is and how it interacts with miR-33. LB-100 is not explicitly mentioned in the provided documents, so we'll have to make an educated guess based on the context of the documents. However, we can look for a similar compound or mechanism that could potentially downregulate miR-33. One possibility is that LB-100 is a small molecule inhibitor of microRNAs, similar to how certain drugs can inhibit specific microRNAs. MicroRNAs, such as miR-33, play a role in regulating gene expression by binding to target mRNAs and preventing their translation. If LB-100 is a microRNA inhibitor, it could potentially downregulate miR-33 by binding to it and preventing its translation. Alternatively, LB-100 could be a protein or a protein complex that interacts with miR-33 and prevents its activity. Without more information about LB-100, it's difficult to provide a definitive answer. However, based on the context of the documents, it's possible that LB-100 could downregulate miR-33.\", \"answer_choice\": \"A\"}}",
    "snippets": [
        {
            "id": "InternalMed_Harrison_5324",
            "title": "InternalMed_Harrison",
            "content": "pluripotency (\u201cground\u201d or \u201cnaive state\u201d). Recent data also indicate that 20\u201325 nucleotide RNAs, called microRNAs (miRNAs), play an important role in regulating stem cell function by repressing the translation of their target genes. For example, it has been shown that miR-21 regulates cell cycle progression in ES cells and miR-128 prevents the differentiation of hematopoietic progenitor cells. These types of analyses should provide molecular clues about the function of stem cells and lead to a more effective means to manipulate stem cells for future therapeutic use."
        },
        {
            "id": "InternalMed_Harrison_6063",
            "title": "InternalMed_Harrison",
            "content": "Number of mutations oncogene, leading to its downregula-101e-7 tion in leukemic cells and apoptosis. As another example of miRNAs\u2019 involvement in oncogenic pathways, the p53 tumor suppressor can transcriptionally induce miR-34 following genotoxic stress, and this induction is important in mediating p53 function. The expression of miRNAs is extremely specific, and there is evi- Number of mutations lineage and differentiation state, as well as cancer diagnosis and outcome prediction. Certain human malignancies are asso ciated with viruses. Examples include Burkitt\u2019s lymphoma (Epstein-Barr virus; Chap. 218), hepatocellular car-Amino acid number cinoma (hepatitis viruses), cervical"
        },
        {
            "id": "InternalMed_Harrison_8486",
            "title": "InternalMed_Harrison",
            "content": "In addition to gene mutations, deregulation of the expression levels of coding genes and of short noncoding RNAs (microRNAs) have been reported to provide prognostic information (Table 132-3). Overexpression of genes such as brain and acute leukemia, cytoplasmic (BAALC), v-ets avian erythroblastosis virus E26 oncogene homologue (avian) (ERG), meningioma (disrupted in balanced translocation) 1 (MN1), and MDS1 and EVI1 complex locus (MECOM, also known as EVI1) have been found to be predictive for poor outcome, especially in CN-AML. Similarly, deregulated expression levels of microRNAs, naturally occurring noncoding RNAs that have been shown to regulate the expression of proteins involved in hematopoietic differentiation and survival pathways by degradation or translation inhibition of target coding RNAs, have been associated with prognosis in AML. Overexpression of miR-155 and miR-3151 has been found to affect outcome adversely in CN-AML, whereas overexpression of miR-181a predicts a"
        },
        {
            "id": "InternalMed_Harrison_8487",
            "title": "InternalMed_Harrison",
            "content": "coding RNAs, have been associated with prognosis in AML. Overexpression of miR-155 and miR-3151 has been found to affect outcome adversely in CN-AML, whereas overexpression of miR-181a predicts a favorable outcome both in CN-AML and cytogenetically abnormal AML."
        },
        {
            "id": "Surgery_Schwartz_10878",
            "title": "Surgery_Schwartz",
            "content": "of these tests have been noted to change depending upon the prevalence of malig-nancy in the tested population (pretest probability). At this time, the ATA guidelines do not advise molecular testing in the work-up of \u201csuspicious for malignancy\u201d nodules. Molecular testing may be used to supplement cytology results for malignancy risk assessment in \u201cAUS/FLUS\u201d or \u201cfollicular/H\u00fcrthle cell neo-plasm/suspicious of the same\u201d nodules depending on feasibility and informed patient preference.40 Expression arrays also have been used to investigate the role of microRNAs, which are a new class of small, noncoding RNAs that have been implicated in carcinogenesis. The specific microRNAs miR-197 and miR-346 are upregulated in follicular thyroid cancers46 and have the potential to be used as diagnostic markers. Additional studies have also demonstrated the feasibility of studying a panel of microRNAs in a small number of FNA samples. ThyGenX/ThyraMIR uses a mutation panel supplemented with 10 miRNA"
        },
        {
            "id": "Obstentrics_Williams_294",
            "title": "Obstentrics_Williams",
            "content": "Last, cenain micro RNA species mediate vascular remodeling and uterine blood low early in placentation (Sama, 2015). In particular, members of the miR-1e7-92 clusrer and miR-34 are important in spiral artery remodeling and invasion. Abnormalities of micro-RNA function have been reported in preeclampsia, fetal-growth rescriction, and gestational diaberes."
        },
        {
            "id": "InternalMed_Harrison_5539",
            "title": "InternalMed_Harrison",
            "content": "DNA methylation correlates with age, although the pattern of change is complex. Histone acetylation is regulated by many enzymes including SIRT1, a protein that has marked effects on aging and the response to dietary restriction in many species. miRNAs are a very large group of noncoding lengths of RNA (18\u201325 nucleotides) that inhibit translation of multiple different mRNAs through binding their 3\u2032 untranslated regions (UTRs). The expression of miRNAs usually decreases with aging and is altered in some age-related diseases. Specific miRNAs linked with aging pathways include miR-21 (associated with target of rapamycin pathway) and miR-1 (associated with insulin/insulin-like growth factor 1 pathway)."
        },
        {
            "id": "Surgery_Schwartz_304",
            "title": "Surgery_Schwartz",
            "content": "Expression in mice of an IL-33 that lacks the nuclear localization sequence, results lethal inflammation, suggesting that nuclear localization acts to prevent unregulated extracel-lular release.144 Similar to HMGB1 and other IL-1 family mem-bers, IL-33 lacks a signal sequence for active secretion so that its release is injury-dependent. Once released from damaged cells, full length IL-33 is biologically active, but it can be further pro-cessed by inflammatory proteases to a mature form that exhibits tento thirtyfold higher activity. Il-33 can binds to a member of the IL-1R family, ST2, leading to activation of NF-kB-mediated transcriptional events. ST2+ cells include macrophages, mast cells, Th2 cells, and tissue regulatory T cells (Tregs) which are important controllers of immune homeostasis.Interleukin-2 Family. Interleukin-2 (IL-2) is a multifunc-tional cytokine produced primarily by CD4+ T cells after antigen activation, which plays pivotal roles in the immune response. Other"
        },
        {
            "id": "InternalMed_Harrison_6067",
            "title": "InternalMed_Harrison",
            "content": "MicroRNAs (miRNAs) are small noncoding RNAs 20\u201322 nucleotides in length that are involved in posttranscriptional gene regulation. Studies in chronic lymphocytic leukemia first suggested a link between miRNAs and cancer when miR-15 and miR-16 were found to be deleted or downregulated in the vast majority of tumors. Various miRNAs have since been found abnormally expressed in several human malignancies. Aberrant expression of miRNAs in cancer has been attributed to several mechanisms, such as chromosomal rearrangements, genomic copy number change, epigenetic modifications, defects in miRNA biogenesis pathway, and regulation by transcriptional factors. Somatic mutations of miRNAs have been identified in many cancers, but the exact functional consequences of these changes on cancer development remain to be determined. The SomaMir database (http://compbio.uthsc.edu/SomamiR) catalogs somatic and germ-line miRNA mutations that have been identified in cancer."
        },
        {
            "id": "Cell_Biology_Alberts_6104",
            "title": "Cell_Biology_Alberts",
            "content": "Brown DD & cai L (2007) amphibian metamorphosis. Dev. Biol. 306, 20\u201333. Giraldez aJ, Mishima Y, rihel J et al. (2006) Zebrafish Mir-430 promotes deadenylation and clearance of maternal mrNas. Science 312, 75\u201379. Isshiki t, pearson B, holbrook S & Doe cQ (2001) Drosophila neuroblasts sequentially express transcription factors which specify the temporal identity of their neuronal progeny. Cell 106, 511\u2013521. Lee rc, Feinbaum rL & ambros V (1993) the C. elegans heterochronic gene lin-4 encodes small rNas with antisense complementarity to lin-14. Cell 75, 843\u2013854. Lewis J (2003) autoinhibition with transcriptional delay: a simple mechanism for the zebrafish somitogenesis oscillator. Curr. Biol. 13, 1398\u20131408. pourqui\u00e9 O (2011) Vertebrate segmentation: from cyclic gene networks to scoliosis. Cell 145, 650\u2013663. Song J, Irwin J & Dean c (2013) remembering the prolonged cold of winter.Curr. Biol. 23, r807\u2013r811."
        },
        {
            "id": "Surgery_Schwartz_3445",
            "title": "Surgery_Schwartz",
            "content": "that targeting two or more pathways may also increase the toxicity profile, particularly if target specificity is limited. When attempted, off-target toxic-ity has been demonstrated with combination small-molecule therapy. In contrast, multitargeting bifunctional short hairpin (bi-shRNA) DNA vectors are designed to limit off-target effect given the high specificity for the genes they are designed to target.Exogenously applied hairpin constructs can be designed to be incorporated into cleavage-dependent RISC or cleav-age-independent RISC complexes, or both. The concept of a bifunctional shRNA37 is to increase knockdown efficiency without loss of sequence specificity by engaging both siRNA and miRNA-like (i.e., common biogenic pathway but comple-mentary to target sequence) RISCs, thereby concurrently acti-vating nucleolytic (Ago2-RISC) and nonnucleolytic (Ago1, 3, 4 \u00b1 Ago2-RISC) processes.38 Each bi-shRNA contains both a matched stem sequence to promote Ago2-mediated passenger strand"
        },
        {
            "id": "Surgery_Schwartz_303",
            "title": "Surgery_Schwartz",
            "content": "cytokines by acting directly to increase in cell adhesion molecule expression, nitric oxide synthesis, and chemokine production by macrophages.140In a cohort of critically ill patients with acute lung injury and ARDS, inflammasome-related mRNA transcripts (CASP1, IL1B, and IL18) were increased in peripheral blood. Moreover, plasma IL-18 were also elevated and served as a marker of mor-tality risk.141 Recent studies suggest that IL-18 therapy may hold promise as effective therapy in promoting immune recovery after severe surgical stress.142IL-33, a second important IL-1 family member, is mainly expressed in surface epithelium and endothelium, where it is normally bound via an N-terminal chromatin-binding motif.143 Nuclear localization is important for its function and perhaps its regulation. Expression in mice of an IL-33 that lacks the nuclear localization sequence, results lethal inflammation, suggesting that nuclear localization acts to prevent unregulated extracel-lular release.144"
        },
        {
            "id": "InternalMed_Harrison_6068",
            "title": "InternalMed_Harrison",
            "content": "Functionally, miRNAs have been suggested to contribute to tumorigenesis through their ability to regulate oncogenic signaling pathways. For example, miR-15 and miR-16 have been shown to target the BCL2 several HPV types, and some of these types have been associated with the development of several malignancies, including cervical, vulvar, vaginal, penile, anal, and oropharyngeal cancer. Viruses are not sufficient for cancer development, but constitute one alteration in the multistep process of cancer progression."
        },
        {
            "id": "Physiology_Levy_1514",
            "title": "Physiology_Levy",
            "content": "A microRNA (miR-222) has been shown to be important for cardiac growth in response to exercise. It also appeared to inhibit maladaptive remodeling of the heart after ischemia/ reperfusion injury. Amodestelevationinintracellular[Ca++](asaresultofincreasedcontractileactivity,forexample),hasbeenproposedtoactivateaCa++/calmodulin-dependentproteinphosphatase(calcineurin) thatcandephosphorylatethetranscriptionfactornuclear factor of activated T cells (NFAT), therebyfacilitatingtranslocationofNFATtothenucleusandultimatelypromotingproteinsynthesisandthushypertrophy( Fig.13.7 ).ActivationofCa++/calmodulin-dependentproteinkinasehasalsobeenimplicatedinactivationofthetranscriptionfactormyocyte enhancer factor 2 (MEF2) bypromotingthedissociation(nuclearexport)ofaninhibitorofMEF2(namely,histone deacetylase [HDAC])."
        },
        {
            "id": "InternalMed_Harrison_25042",
            "title": "InternalMed_Harrison",
            "content": "with severe disease, anti-DNA, nephritis, and antiphospholipid syndrome, and an allele of FCGRIIA encoding a receptor that binds immune complexes poorly and predisposes to nephritis. Some gene effects are in promoter regions (e.g., IL-10), and others are conferred by copy numbers (e.g., C4A). In addition to genome-encoded susceptibility and protective genes, the influence of certain microRNAs (miRNAs) on gene transcription, as well as posttranscriptional epigenetic modification of DNA (which is hypomethylated in T cells of SLE patients), probably play major roles in disease susceptibility."
        },
        {
            "id": "Cell_Biology_Alberts_2053",
            "title": "Cell_Biology_Alberts",
            "content": "Several features make miRNAs especially useful regulators of gene expression. First, a single miRNA can regulate a whole set of different mRNAs, so long as the mRNAs carry a common short sequence in their UTRs. This situation is common in humans, where a single miRNA can control hundreds of different mRNAs. Second, regulation by miRNAs can be combinatorial. When the base-pairing between the miRNA and mRNA fails to trigger cleavage, additional miRNAs binding to the same mRNA lead to further reductions in its translation. As discussed earlier for transcription regulators, combinatorial control greatly expands the possibilities available to the cell by linking gene expression to a combination of different regulators rather than a single regulator. Third, an miRNA occupies relatively little"
        },
        {
            "id": "Cell_Biology_Alberts_2055",
            "title": "Cell_Biology_Alberts",
            "content": "3\u02dc OH (end of RNA) active site, showing 2 Mg2+ atoms needed for \u201cslicing\u201d space in the genome when compared with a protein. Indeed, their small size is one reason that miRNAs were discovered only recently. Although we are only beginning to appreciate the full impact of miRNAs, it is clear that they represent an important part of the cell\u2019s equipment for regulating the expression of genes. We discuss specific examples of miRNAs that have key roles in development in Chapter 21. rnA interference is Also Used as a Cell Defense Mechanism"
        },
        {
            "id": "InternalMed_Harrison_6154",
            "title": "InternalMed_Harrison",
            "content": "Epigenetic gene regulation can also occur via microRNAs or long non-coding RNAs (lncRNAs). MicroRNAs are short (average 22 nucleotides in length) RNA molecules that silence gene expression after transcription by binding and inhibiting the translation or promoting the degradation of mRNA transcripts. It is estimated that more than 1000 microRNAs are encoded in the human genome. Each tissue has a distinctive repertoire of microRNA expression, and this pattern is altered in specific ways in cancers. However, specific correlations between microRNA expression and tumor biology and clinical behavior are just now emerging. Therapies targeting microRNAs are not currently at hand but represent a novel area of treatment development. lncRNAs are longer than 200 nucleotides and compose the largest group of noncoding RNAs. Some of them have been shown to play important roles in gene regulation. The potential for altering these RNAs for therapeutic benefit is an area of active investigation,"
        },
        {
            "id": "Immunology_Janeway_4528",
            "title": "Immunology_Janeway",
            "content": "A-36 Knockdown of gene expression by RNA interference (RNAi)."
        },
        {
            "id": "Cell_Biology_Alberts_183",
            "title": "Cell_Biology_Alberts",
            "content": "Figure 1\u201347 A very simple regulatory circuit\u2014a single gene regulating its own expression by the binding of its protein product to its own regulatory DNA. simple schematic diagrams such as this are found throughout this book. They are often used to summarize what we know, but they leave many questions unanswered. When the protein binds, does it inhibit or stimulate transcription from the gene? how steeply does the transcription rate depend on the protein concentration? how long, on average, does a molecule of the protein remain bound to the dnA? how long does it take to make each molecule of mRnA or protein, and how quickly does each type of molecule get degraded? As explained in chapter 8, mathematical modeling shows that we need quantitative answers to all these and other questions before we can predict the behavior of even this single-gene system. For different parameter values, the system may settle to a unique steady state; or it may behave as a switch, capable of existing in one"
        },
        {
            "id": "Pathology_Robbins_1210",
            "title": "Pathology_Robbins",
            "content": "As discussed in Chapter 1, microRNAs (miRNAs) are non-coding, single-stranded RNAs, approximately 22 nucleotides in length, that function as negative regulators of genes. They inhibit gene expression posttranscriptionally by repressing translation or, in some cases, by messenger RNA (mRNA) cleavage. In view of their important functions in control of cell growth, differentiation, and survival, it is not surprising that accumulating evidence indicates that miRNAs also can contribute to carcinogenesis. Specifically, if the target of a miRNA is a tumor suppressor gene, then overactivity of the miRNA can reduce the tumor suppressor protein. Such miRNAs are sometimes referred to as oncomIRs. Conversely, if an miRNA inhibits the translation of an oncogene, a reduction in the quantity or function of that miRNA will lead to overproduction of the oncogene product. Such relationships have already been established by miRNA profiling of several human tumors. For example, downregulation or deletion"
        },
        {
            "id": "Pathology_Robbins_1211",
            "title": "Pathology_Robbins",
            "content": "of that miRNA will lead to overproduction of the oncogene product. Such relationships have already been established by miRNA profiling of several human tumors. For example, downregulation or deletion of certain miRNAs in some leukemias and lymphomas results in increased expression of BCL2, an anti-apoptotic gene. Thus, by negatively regulating BCL2, such miRNAs behave as tumor suppressor genes. Dysregulation of other miRNAs that control the expression of the RAS and MYC oncogenes also has been detected in lung tumors and in certain B-cell leukemias, respectively."
        },
        {
            "id": "Cell_Biology_Alberts_2535",
            "title": "Cell_Biology_Alberts",
            "content": "A simple case of positive feedback can be seen in a regulatory system in which a transcription regulator activates (directly or indirectly) its own expression, as in Figure 8\u201380A. Positive feedback can also arise in a circuit with many intervening repressors or activators, so long as the net overall effect of the interactions is activation (Figure 8\u201380B and C)."
        },
        {
            "id": "Pathology_Robbins_1768",
            "title": "Pathology_Robbins",
            "content": "In contrast to syndromic Wilms tumors, the molecular abnormalities underlying sporadic (i.e., nonsyndromic) tumors, which account for 90% of cases overall in children, are only recently being elucidated. Some of them are associated with specific histologic features described later. For example, gain-of-function mutations of the gene encoding \u03b2-catenin (Chapter 6) have been demonstrated in approximately 10% of sporadic Wilms tumors. Other recurrent mutations occur in genes encoding proteins involved in microRNA processing (DROSHA, DGCR8, and DICER1); these are seen in 15% to 20% of Wilms tumors with predominantly blastemal histology (see later). It is postulated that aberrations in microRNA processing lead to reduced levels of many mature microRNAs, in particular in the miR-200 family, which is involved in \u201cmesenchymal to epithelial transformation\u201d during renal morphogenesis. The lack of mesenchymal to epithelial transformation likely leads to persistent blastemal \u201crests\u201d in the kidney"
        },
        {
            "id": "Cell_Biology_Alberts_5764",
            "title": "Cell_Biology_Alberts",
            "content": "1000 human genes encode transcription regulators, but only about 250 yeast genes do so. As we shall see, the development of animals is dominated by cell\u2013cell interactions and by differential gene expression. The third class of non-coding RNAs has a more uncertain status: it includes genes that encode microR-NAs (miRNAs); there are at least 500 of these in humans. Along with the regulatory proteins, they play a significant part in controlling gene expression during animal development, but the full extent of their importance is still unclear. The loss of individual miRNA genes in C. elegans, where their functions have been well studied, rarely leads to obvious phenotypes, suggesting that the roles of miRNAs during animal development are often subtle, serving to fine-tune the developmental machinery rather than to form its core structures."
        },
        {
            "id": "Physiology_Levy_1513",
            "title": "Physiology_Levy",
            "content": "The cellular and molecular mechanisms underlying the development of cardiac hypertrophy are not clear, although an elevation in intracellular [Ca++] has been implicated. The link or links between cardiac hypertrophy, decreased cardiac performance, and impaired \u03b2-adrenergic response during chronic pressure overload are unclear. Decreased cardiac performance has been attributed to dysregulation of intracellular [Ca++]. Alterations in the level, activity, and phosphorylation status of a variety of proteins, including L-type calcium channels, phospholamban, SERCA, and RYR, have all been implicated in the Ca++ dysregulation associated with a failing heart (pathological hypertrophy). A microRNA (miR-222) has been shown to be important for cardiac growth in response to exercise. It also appeared to inhibit maladaptive remodeling of the heart after ischemia/ reperfusion injury."
        },
        {
            "id": "Cell_Biology_Alberts_695",
            "title": "Cell_Biology_Alberts",
            "content": "P. da Fonseca et al., Nature 470:274\u2013278, 2011. With permission from Macmillan Publishers Ltd.)"
        },
        {
            "id": "Pharmacology_Katzung_4230",
            "title": "Pharmacology_Katzung",
            "content": "JP is a 33-year-old woman who presents with complaints of fatigue requiring daytime naps, weight gain, cold intoler-ance, and muscle weakness for the last few months. These complaints are new since she used to always feel \u201chot,\u201d noted difficulty sleeping, and could eat anything that she wanted without gaining weight. She also would like to become preg-nant in the near future. Because of poor medication adherence to methimazole and propranolol, she received radioactive iodine (RAI) therapy, developed hypothyroidism, and was started on levothyroxine 100 mcg daily. Other medications include calcium carbonate three times daily to \u201cprotect her bones\u201d and omeprazole for \u201cheartburn.\u201d On physical exami-nation, her blood pressure is 130/89 mm Hg with a pulse of 50 bpm. Her weight is 136 lb (61.8 kg), an increase of 10 lb (4.5 kg) in the last year. Her thyroid gland is not palpable and her reflexes are delayed. Laboratory findings include a thyroid-stimulating hormone (TSH) level of 24.9 \u03bcIU/mL"
        },
        {
            "id": "Cell_Biology_Alberts_6343",
            "title": "Cell_Biology_Alberts",
            "content": "22\u201310 Generation of induced pluripotent stem (iPS) cells was first accomplished using retroviral vectors to carry the OSKM (Oct4, Sox2, Klf4, and Myc) set of transcription regulators into cells. The efficiency of fibroblast reprogramming was typically low (0.01%), in part because large numbers of retroviruses must integrate to bring about reprogramming and each integration event carries with it the risk of inappropriately disrupting or activating a critical gene. In what other ways, or other forms, do you suppose you might deliver the OSKM transcription regulators so as to avoid these problems? percent of \u02dc cellsexpressing HPAP number of colonies cells (problem 22\u20139)."
        },
        {
            "id": "Cell_Biology_Alberts_5212",
            "title": "Cell_Biology_Alberts",
            "content": "0.5 \u00b5m 100 nm"
        },
        {
            "id": "Surgery_Schwartz_516",
            "title": "Surgery_Schwartz",
            "content": "J, et al. A genomic storm in critically injured humans. J Exp Med. 2011;208(13): 2581-2590. doi: 10.1084/jem.20111354 4. Lowry SF. Human endotoxemia: a model for mechanistic insight and therapeutic targeting. Shock. 2005;24(suppl 1):94-100. 5. Pugin J. How tissue injury alarms the immune system and causes a systemic inflammatory response syndrome. Ann Intensive Care. 2012;2(1):27. doi: 10.1186/2110-5820-2-27 6. Manson J, Thiemermann C, Brohi K. Trauma alarmins as activators of damage-induced inflammation. Br J Surg. 2012;99(suppl 1):12-20. doi: 10.1002/bjs.7717 7. Chan JK, Roth J, Oppenheim JJ, et al. Alarmins: awaiting a clinical response. J Clin Invest. 2012;122(8):2711-2719. doi: 10.1172/JCI62423 8. Bertheloot D, Latz E. HMGB1, IL-1alpha, IL-33 and S100 proteins: dual-function alarmins. Cell Mol Immunol. 2017;14(1):43-64. doi: 10.1038/cmi.2016.34 9. Fontaine M, Lepape A, Piriou V, Venet F, Friggeri A. Innate danger signals in acute injury: From bench to bedside. Anaesth Crit Care"
        },
        {
            "id": "Biochemistry_Lippincott_1300",
            "title": "Biochemistry_Lippinco",
            "content": "2. Anthropometric measures: These are physical measures of the body. They include (but are not limited to) weight, height, body mass index (an indicator of obesity, see p. 349), skin-fold thickness (an indicator of subcutaneous fat), and waist circumference (an indicator of abdominal fat, see p. 349). [Note: Ideal body weight can be calculated using the Hamwi method: 106 lb (for males) or 100 lb (for females) for the first 5 ft of height + 5 lb for every inch over 5 ft, with an adjustment of \u221210% for a small frame and + 10% for a large one.] 3."
        }
    ],
    "scores": [
        0.028346047156726766,
        0.027120800239564764,
        0.026567237271441696,
        0.026157249829816202,
        0.025763125763125765,
        0.02490146130368704,
        0.024894695947327527,
        0.023509986745280865,
        0.019334952363160844,
        0.017494270435446907,
        0.01743877473652286,
        0.017427884615384616,
        0.017139090309822018,
        0.016270416850602258,
        0.016083376222336594,
        0.016018306636155607,
        0.0153011704253497,
        0.014929514929514928,
        0.014533870887462047,
        0.0145224171539961,
        0.013701201201201201,
        0.013682493657122145,
        0.011947011490213991,
        0.011729108587747332,
        0.01133981322660568,
        0.011142147734326506,
        0.009900990099009901,
        0.00980392156862745,
        0.00980392156862745,
        0.00980392156862745,
        0.00980392156862745,
        0.009708737864077669
    ]
}